menu
    • menu

    Company profile for Rampex Labs

    Mix Gif-PSE
    News
    Ipsen's ADC push leads to $1B deal for preclinical Simcere drug

    24 Dec 2025

    // GLOBENEWSWIRE

    Gilead pays $35M to license pair of HSV assets from Assembly Bio

    24 Dec 2025

    // BUSINESSWIRE

    Boehringer Spells Out A $448M Future For Rectify's ABC Program

    24 Dec 2025

    // FIERCE BIOTECH

    DATA COMPILATION
    #PharmaFlow

    #1

    Contact Supplier

    Website

    CPhI Milan

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content

    radio-compass-blog/antibiotic-market-to-reach-us-74-07-billion-by-2033-fda-approves-gsk-s-blujepa-for-uncomplicated-utis

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    PharmaCompass

    Rampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

    Related CompaniesRelated Companies

    About

    Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rampex Labsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Plot No. 151, S.V. Co-Operative Indl.Estate, Village Road, IDA Bollaram, Sanga...
    Telephone
    Telephone
    +91 9618020099
    Client Email
    Email
    apisales@rampexlabs.com
    Client Website
    Website
    http://www.rampexlabs.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/rampex-labs-private-limitedhyderabad/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/rampex-labs-party-content-20078.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    LISTED APIs

    read-more
    read-more
    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

      Chlorzoxazone

      Product
      Web Link

      Stock Recap
      #PipelineProspector

      Market
      Place

      Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex ...
      Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
      Company Banner

      01

      Chlorzoxazone

      India
      arrow
      CPhI Milan
      Attending
      • fda
      • EDQM
      • WHO-GMP
      Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

      Rampex Labs

      Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

      About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced i...

      Company Banner

      Product
      Web Link

      Stock Recap
      #Pipeline Prospector

      Market
      Place

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

        Cinacalcet Hydrochloride

        Product
        Web Link

        Stock Recap
        #PipelineProspector

        Market
        Place

        Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex ...
        Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
        Company Banner

        02

        Cinacalcet Hydrochloride

        India
        arrow
        CPhI Milan
        Attending
        • fda
        • EDQM
        • WHO-GMP
        Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

        Rampex Labs

        Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

        About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced i...

        Company Banner

        Product
        Web Link

        Stock Recap
        #Pipeline Prospector

        Market
        Place

        Contact Supplier
          • fda
          • EDQM
          • WHO-GMP
          Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

          Olanzapine

          Product
          Web Link

          Stock Recap
          #PipelineProspector

          Market
          Place

          Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex ...
          Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
          Company Banner

          03

          Olanzapine

          India
          arrow
          CPhI Milan
          Attending
          • fda
          • EDQM
          • WHO-GMP
          Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

          Rampex Labs

          Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

          About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced i...

          Company Banner

          Product
          Web Link

          Stock Recap
          #Pipeline Prospector

          Market
          Place

          Contact Supplier
            • fda
            • EDQM
            • WHO-GMP
            Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

            Olanzapine Pamoate

            Product
            Web Link

            Stock Recap
            #PipelineProspector

            Market
            Place

            Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex ...
            Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
            Company Banner

            04

            Olanzapine Pamoate

            India
            arrow
            CPhI Milan
            Attending
            • fda
            • EDQM
            • WHO-GMP
            Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

            Rampex Labs

            Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

            About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced i...

            Company Banner

            Product
            Web Link

            Stock Recap
            #Pipeline Prospector

            Market
            Place

            Contact Supplier
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

              Olanzapine Tartrate

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex ...
              Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
              Company Banner

              05

              Olanzapine Tartrate

              India
              arrow
              CPhI Milan
              Attending
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

              Rampex Labs

              Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

              About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced i...

              Company Banner

              Product
              Web Link

              Stock Recap
              #Pipeline Prospector

              Market
              Place

              Contact Supplier
                • fda
                • EDQM
                • WHO-GMP
                Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                Ondansetron Hydrochloride

                Product
                Web Link

                Stock Recap
                #PipelineProspector

                Market
                Place

                Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex ...
                Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
                Company Banner

                06

                Ondansetron Hydrochloride

                India
                arrow
                CPhI Milan
                Attending
                • fda
                • EDQM
                • WHO-GMP
                Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                Rampex Labs

                Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

                About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced i...

                Company Banner

                Product
                Web Link

                Stock Recap
                #Pipeline Prospector

                Market
                Place

                Only 10 entries up to this point, click to access all click full view read-more
                click full view
                Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

                ALL Intermediates

                read-more
                read-more
                Contact Supplier
                  • fda
                  • EDQM
                  • WHO-GMP
                  Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                  1-(2,3-Dichlorophenyl) Piperazine

                  Portfolio PDF

                  Product Web Link

                  Virtual Booth

                  Digital Content

                  Website

                  Corporate PDF

                  41202-77-1
                  Aripiprazole
                  Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-a...
                  Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
                  Company Banner

                  01

                  1-(2,3-Dichlorophenyl) Piperazine

                  India
                  CPhI Milan
                  Attending
                  arrow
                  • fda
                  • EDQM
                  • WHO-GMP
                  Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                  Rampex Labs

                  1-(2,3-Dichlorophenyl) Piperazine

                  CAS Number : 41202-77-1

                  End Use API : Aripiprazole

                  About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities i...

                  Company Banner

                  Intermediate Web Link

                  Market Place

                  Contact Supplier
                    • fda
                    • EDQM
                    • WHO-GMP
                    Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                    1-(2,3-Dichlorophenyl) Piperazine Hydrochloride

                    Intermediate Web Link

                    Market Place

                    119532-26-2
                    Aripiprazole
                    Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-a...
                    Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
                    Company Banner

                    02

                    1-(2,3-Dichlorophenyl) Piperazine Hydrochloride

                    India
                    CPhI Milan
                    Attending
                    arrow
                    • fda
                    • EDQM
                    • WHO-GMP
                    Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                    Rampex Labs

                    1-(2,3-Dichlorophenyl) Piperazine Hydrochloride

                    CAS Number : 119532-26-2

                    End Use API : Aripiprazole

                    About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities i...

                    Company Banner

                    Intermediate Web Link

                    Market Place

                    Contact Supplier
                      • fda
                      • EDQM
                      • WHO-GMP
                      Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                      7-Hydroxy 3,4-Dihydro Carbostyril

                      Intermediate Web Link

                      Market Place

                      22246-18-0
                      Aripiprazole
                      Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-a...
                      Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
                      Company Banner

                      03

                      7-Hydroxy 3,4-Dihydro Carbostyril

                      India
                      CPhI Milan
                      Attending
                      arrow
                      • fda
                      • EDQM
                      • WHO-GMP
                      Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                      Rampex Labs

                      7-Hydroxy 3,4-Dihydro Carbostyril

                      CAS Number : 22246-18-0

                      End Use API : Aripiprazole

                      About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities i...

                      Company Banner

                      Intermediate Web Link

                      Market Place

                      Contact Supplier
                        • fda
                        • EDQM
                        • WHO-GMP
                        Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                        7-(4-Bromobutoxy)-3,4-Dihydrocarbostyril

                        Intermediate Web Link

                        Market Place

                        129722-34-5
                        Aripiprazole
                        Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-a...
                        Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
                        Company Banner

                        04

                        7-(4-Bromobutoxy)-3,4-Dihydrocarbostyril

                        India
                        CPhI Milan
                        Attending
                        arrow
                        • fda
                        • EDQM
                        • WHO-GMP
                        Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                        Rampex Labs

                        7-(4-Bromobutoxy)-3,4-Dihydrocarbostyril

                        CAS Number : 129722-34-5

                        End Use API : Aripiprazole

                        About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities i...

                        Company Banner

                        Intermediate Web Link

                        Market Place

                        Contact Supplier
                          • fda
                          • EDQM
                          • WHO-GMP
                          Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                          N-Benzhydryl Piperazine

                          Intermediate Web Link

                          Market Place

                          841-77-0
                          Cinnarizine
                          Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-a...
                          Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
                          Company Banner

                          05

                          N-Benzhydryl Piperazine

                          India
                          CPhI Milan
                          Attending
                          arrow
                          • fda
                          • EDQM
                          • WHO-GMP
                          Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                          Rampex Labs

                          N-Benzhydryl Piperazine

                          CAS Number : 841-77-0

                          End Use API : Cinnarizine

                          About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities i...

                          Company Banner

                          Intermediate Web Link

                          Market Place

                          Contact Supplier
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                            (S)-(+)-3-Quinuclidinol

                            Intermediate Web Link

                            Market Place

                            34583-34-1
                            Venglustat
                            Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-a...
                            Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
                            Company Banner

                            06

                            (S)-(+)-3-Quinuclidinol

                            India
                            CPhI Milan
                            Attending
                            arrow
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                            Rampex Labs

                            (S)-(+)-3-Quinuclidinol

                            CAS Number : 34583-34-1

                            End Use API : Venglustat

                            About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities i...

                            Company Banner

                            Intermediate Web Link

                            Market Place

                            Contact Supplier
                              • fda
                              • EDQM
                              • WHO-GMP
                              Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                              2-Aminomethyl-7-Chloro-2,3-Dihydro-5-(2-Fluorophenyl)-1H-1,4-B...

                              Intermediate Web Link

                              Market Place

                              59469-29-3
                              Midazolam
                              Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-a...
                              Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
                              Company Banner

                              07

                              2-Aminomethyl-7-Chloro-2,3-Dihydro-5-(2-Fluorophenyl)-1H-1,4-Benzodiazepine Dimaleate

                              India
                              CPhI Milan
                              Attending
                              arrow
                              • fda
                              • EDQM
                              • WHO-GMP
                              Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                              Rampex Labs

                              2-Aminomethyl-7-Chloro-2,3-Dihydro-5-(2-Fluorophenyl)-1H-1,4-B...

                              CAS Number : 59469-29-3

                              End Use API : Midazolam

                              About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities i...

                              Company Banner

                              Intermediate Web Link

                              Market Place

                              Contact Supplier
                                • fda
                                • EDQM
                                • WHO-GMP
                                Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                                2-Amino-5-Methylthiophene-3-Carbonitrile

                                Intermediate Web Link

                                Market Place

                                138564-58-6
                                Olanzapine
                                Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-a...
                                Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
                                Company Banner

                                08

                                2-Amino-5-Methylthiophene-3-Carbonitrile

                                India
                                CPhI Milan
                                Attending
                                arrow
                                • fda
                                • EDQM
                                • WHO-GMP
                                Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                                Rampex Labs

                                2-Amino-5-Methylthiophene-3-Carbonitrile

                                CAS Number : 138564-58-6

                                End Use API : Olanzapine

                                About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities i...

                                Company Banner

                                Intermediate Web Link

                                Market Place

                                Contact Supplier
                                  • fda
                                  • EDQM
                                  • WHO-GMP
                                  Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                                  5-Methyl-2-[(2-Nitrophenyl) Amino] Thiophene-3-Carbonitrile

                                  Intermediate Web Link

                                  Market Place

                                  138564-59-7
                                  Olanzapine
                                  Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-a...
                                  Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
                                  Company Banner

                                  09

                                  5-Methyl-2-[(2-Nitrophenyl) Amino] Thiophene-3-Carbonitrile

                                  India
                                  CPhI Milan
                                  Attending
                                  arrow
                                  • fda
                                  • EDQM
                                  • WHO-GMP
                                  Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                                  Rampex Labs

                                  5-Methyl-2-[(2-Nitrophenyl) Amino] Thiophene-3-Carbonitrile

                                  CAS Number : 138564-59-7

                                  End Use API : Olanzapine

                                  About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities i...

                                  Company Banner

                                  Intermediate Web Link

                                  Market Place

                                  Contact Supplier
                                    • fda
                                    • EDQM
                                    • WHO-GMP
                                    Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                                    4-Amino-2-Methyl-10H-Thieno [2, 3-B] [1, 5] Benzodiazepine Hyd...

                                    Intermediate Web Link

                                    Market Place

                                    138564-60-0
                                    Olanzapine
                                    Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-a...
                                    Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in advanced intermediates and key starting materials, while the Vizag unit extends to API production. With a strong focus on quality, compliance, and innovation, Rampex Labs is committed to delivering reliable solutions for the global pharmaceutical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
                                    Company Banner

                                    10

                                    4-Amino-2-Methyl-10H-Thieno [2, 3-B] [1, 5] Benzodiazepine Hydrochloride

                                    India
                                    CPhI Milan
                                    Attending
                                    arrow
                                    • fda
                                    • EDQM
                                    • WHO-GMP
                                    Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

                                    Rampex Labs

                                    4-Amino-2-Methyl-10H-Thieno [2, 3-B] [1, 5] Benzodiazepine Hyd...

                                    CAS Number : 138564-60-0

                                    End Use API : Olanzapine

                                    About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities i...

                                    Company Banner

                                    Intermediate Web Link

                                    Market Place

                                    Only 10 entries up to this point, click to access all click full view read-more
                                    click full view
                                    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

                                    KEY PRODUCTS

                                    read-more
                                    read-more

                                    TOP RANKED SUPPLIER FOR:

                                    Sponsored Ads.
                                    full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view
                                    Sponsored Ads.full-view

                                    ABOUT THIS PAGE

                                    Contact Rampex Labs and get a quotation

                                    Rampex Labs is a supplier offers 8 products (APIs, Excipients or Intermediates).

                                    Find a price of Olanzapine bulk with CEP, WC offered by Rampex Labs

                                    Find a price of CAS 2378-95-2 bulk with DMF offered by Rampex Labs

                                    Find a price of Chlorzoxazone bulk with DMF offered by Rampex Labs

                                    Find a price of Olanzapine bulk with CEP offered by Rampex Labs

                                    Find a price of Cinacalcet Hydrochloride bulk offered by Rampex Labs

                                    Find a price of Olanzapine Pamoate bulk offered by Rampex Labs

                                    Find a price of Olanzapine Tartrate bulk offered by Rampex Labs

                                    Find a price of Ondansetron Hydrochloride bulk offered by Rampex Labs

                                    Ask Us for Pharmaceutical Supplier and Partner
                                    Ask Us, Find A Supplier / Partner
                                    No Commissions, No Strings Attached, Get Connected for FREE

                                    What are you looking for?

                                    How can we help you?

                                    The request can't be empty

                                    Please read our Privacy Policy carefully

                                    You must agree to the privacy policy

                                    The name can't be empty
                                    The company can't be empty.
                                    The email can't be empty Please enter a valid email.
                                    The mobile can't be empty
                                    • Privacy policy
                                    • Terms and conditions
                                    • Disclaimers
                                    • LinkedIn
                                    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

                                    Market Place

                                    Market Place

                                    PharmaCompass

                                    Home

                                    Market Place

                                    Menu

                                    Post Enquiry

                                    Post Enquiry

                                    Market Place

                                    Market Place

                                    Search